Loading...
IDT Australia Limited
IDT.AX•ASX
HealthcareDrug Manufacturers - Specialty & Generic
A$0.10
A$0.003(3.09%)
IDT Australia Limited (IDT.AX) Financial Performance & Statements
Review IDT Australia Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
90.71%
↑ 90.71%
Operating Income Growth
49.38%
↑ 49.38%
Net Income Growth
36.30%
↑ 36.30%
Operating Cash Flow Growth
-21.51%
↓ 21.51%
Operating Margin
-19.86%
↓ 19.86%
Gross Margin
53.29%
↑ 53.29%
Net Profit Margin
-25.58%
↓ 25.58%
ROE
-19.17%
↓ 19.17%
ROIC
-13.88%
↓ 13.88%
IDT Australia Limited (IDT.AX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for IDT Australia Limited stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $8.29M | $5.73M | $4.53M | $2.43M |
| Cost of Revenue | $3.21M | $6.57M | $5.24M | $5.22M |
| Gross Profit | $5.08M | -$841000.00 | -$713000.00 | -$2.79M |
| Gross Profit Ratio | $0.61 | -$0.15 | -$0.16 | -$1.15 |
| R&D Expenses | $441000.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $6.70M | $2.54M | $3.05M | $1.75M |
| Operating Expenses | $7.14M | $2.54M | $2.99M | $1.75M |
| Total Costs & Expenses | $10.35M | $9.11M | $8.23M | $6.98M |
| Interest Income | $0.00 | $31000.00 | $4000.00 | $4000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $436000.00 | $489000.00 | $427000.00 | $612000.00 |
| EBITDA | -$1.56M | -$3.55M | -$3.38M | -$5.47M |
| EBITDA Ratio | -$0.19 | -$0.50 | -$0.72 | -$1.62 |
| Operating Income | -$2.06M | -$3.38M | -$3.70M | -$4.55M |
| Operating Income Ratio | -$0.25 | -$0.59 | -$0.82 | -$1.87 |
| Other Income/Expenses (Net) | $22000.00 | -$1.15M | $0.00 | -$1.53M |
| Income Before Tax | -$2.04M | -$4.04M | -$3.70M | -$6.08M |
| Income Before Tax Ratio | -$0.25 | -$0.70 | -$0.82 | -$2.50 |
| Income Tax Expense | -$485000.00 | -$177000.00 | -$1.02M | -$261000.00 |
| Net Income | -$1.55M | -$3.86M | -$2.68M | -$5.81M |
| Net Income Ratio | -$0.19 | -$0.67 | -$0.59 | -$2.39 |
| EPS | -$0.004 | -$0.01 | -$0.01 | -$0.02 |
| Diluted EPS | -$0.004 | -$0.01 | -$0.01 | -$0.02 |
| Weighted Avg Shares Outstanding | $351.69M | $353.99M | $258.07M | $247.24M |
| Weighted Avg Shares Outstanding (Diluted) | $351.65M | $353.99M | $258.07M | $247.24M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan